255 related articles for article (PubMed ID: 18534982)
21. 2-Arachidonoyl-glycerol suppresses interferon-gamma production in phorbol ester/ionomycin-activated mouse splenocytes independent of CB1 or CB2.
Kaplan BL; Ouyang Y; Rockwell CE; Rao GK; Kaminski NE
J Leukoc Biol; 2005 Jun; 77(6):966-74. PubMed ID: 15774549
[TBL] [Abstract][Full Text] [Related]
22. Neuronal protease-activated receptor 1 drives synaptic retrograde signaling mediated by the endocannabinoid 2-arachidonoylglycerol.
Hashimotodani Y; Ohno-Shosaku T; Yamazaki M; Sakimura K; Kano M
J Neurosci; 2011 Feb; 31(8):3104-9. PubMed ID: 21414931
[TBL] [Abstract][Full Text] [Related]
23. 2-Arachidonoylglycerol elicits neuroprotective effects on excitotoxically lesioned dentate gyrus granule cells via abnormal-cannabidiol-sensitive receptors on microglial cells.
Kreutz S; Koch M; Böttger C; Ghadban C; Korf HW; Dehghani F
Glia; 2009 Feb; 57(3):286-94. PubMed ID: 18837048
[TBL] [Abstract][Full Text] [Related]
24. Acute neuronal injury, excitotoxicity, and the endocannabinoid system.
van der Stelt M; Veldhuis WB; Maccarrone M; Bär PR; Nicolay K; Veldink GA; Di Marzo V; Vliegenthart JF
Mol Neurobiol; 2002; 26(2-3):317-46. PubMed ID: 12428763
[TBL] [Abstract][Full Text] [Related]
25. Endocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown.
Reggio PH
Curr Med Chem; 2010; 17(14):1468-86. PubMed ID: 20166921
[TBL] [Abstract][Full Text] [Related]
26. Possible inhibitory role of endogenous 2-arachidonoylglycerol as an endocannabinoid in (±)-epibatidine-induced activation of central adrenomedullary outflow in the rat.
Shimizu T; Tanaka K; Shimizu S; Higashi Y; Yawata T; Nakamura K; Taniuchi K; Ueba T; Yuri K; Saito M
Neuropharmacology; 2015 Aug; 95():278-89. PubMed ID: 25882827
[TBL] [Abstract][Full Text] [Related]
27. Genetic deletion of monoacylglycerol lipase alters endocannabinoid-mediated retrograde synaptic depression in the cerebellum.
Zhong P; Pan B; Gao XP; Blankman JL; Cravatt BF; Liu QS
J Physiol; 2011 Oct; 589(Pt 20):4847-55. PubMed ID: 21911610
[TBL] [Abstract][Full Text] [Related]
28. Endocannabinoid- and mGluR5-dependent short-term synaptic depression in an isolated neuron/bouton preparation from the hippocampal CA1 region.
Sheinin A; Talani G; Davis MI; Lovinger DM
J Neurophysiol; 2008 Aug; 100(2):1041-52. PubMed ID: 18497350
[TBL] [Abstract][Full Text] [Related]
29. The endocannabinoid 2-arachidonoylglycerol reduces lesion expansion and white matter damage after spinal cord injury.
Arevalo-Martin A; Garcia-Ovejero D; Molina-Holgado E
Neurobiol Dis; 2010 May; 38(2):304-12. PubMed ID: 20156559
[TBL] [Abstract][Full Text] [Related]
30. Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area.
Mátyás F; Urbán GM; Watanabe M; Mackie K; Zimmer A; Freund TF; Katona I
Neuropharmacology; 2008 Jan; 54(1):95-107. PubMed ID: 17655884
[TBL] [Abstract][Full Text] [Related]
31. Presynaptic monoacylglycerol lipase activity determines basal endocannabinoid tone and terminates retrograde endocannabinoid signaling in the hippocampus.
Hashimotodani Y; Ohno-Shosaku T; Kano M
J Neurosci; 2007 Jan; 27(5):1211-9. PubMed ID: 17267577
[TBL] [Abstract][Full Text] [Related]
32. Detection of Cyclooxygenase-2-Derived Oxygenation Products of the Endogenous Cannabinoid 2-Arachidonoylglycerol in Mouse Brain.
Morgan AJ; Kingsley PJ; Mitchener MM; Altemus M; Patrick TA; Gaulden AD; Marnett LJ; Patel S
ACS Chem Neurosci; 2018 Jul; 9(7):1552-1559. PubMed ID: 29722963
[TBL] [Abstract][Full Text] [Related]
33. The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species.
Siegmund SV; Qian T; de Minicis S; Harvey-White J; Kunos G; Vinod KY; Hungund B; Schwabe RF
FASEB J; 2007 Sep; 21(11):2798-806. PubMed ID: 17440119
[TBL] [Abstract][Full Text] [Related]
34. COX-2 oxidative metabolism of endocannabinoids augments hippocampal synaptic plasticity.
Yang H; Zhang J; Andreasson K; Chen C
Mol Cell Neurosci; 2008 Apr; 37(4):682-95. PubMed ID: 18295507
[TBL] [Abstract][Full Text] [Related]
35. Activation of orexin 1 receptors in the periaqueductal gray of male rats leads to antinociception via retrograde endocannabinoid (2-arachidonoylglycerol)-induced disinhibition.
Ho YC; Lee HJ; Tung LW; Liao YY; Fu SY; Teng SF; Liao HT; Mackie K; Chiou LC
J Neurosci; 2011 Oct; 31(41):14600-10. PubMed ID: 21994376
[TBL] [Abstract][Full Text] [Related]
36. Differential regulation of endocannabinoid synthesis and degradation in the uterus during embryo implantation.
Wang H; Xie H; Sun X; Kingsley PJ; Marnett LJ; Cravatt BF; Dey SK
Prostaglandins Other Lipid Mediat; 2007 Feb; 83(1-2):62-74. PubMed ID: 17259073
[TBL] [Abstract][Full Text] [Related]
37. Agonist-directed trafficking of response by endocannabinoids acting at CB2 receptors.
Shoemaker JL; Ruckle MB; Mayeux PR; Prather PL
J Pharmacol Exp Ther; 2005 Nov; 315(2):828-38. PubMed ID: 16081674
[TBL] [Abstract][Full Text] [Related]
38. Endocannabinoids affect neurological and cognitive function in thioacetamide-induced hepatic encephalopathy in mice.
Avraham Y; Israeli E; Gabbay E; Okun A; Zolotarev O; Silberman I; Ganzburg V; Dagon Y; Magen I; Vorobia L; Pappo O; Mechoulam R; Ilan Y; Berry EM
Neurobiol Dis; 2006 Jan; 21(1):237-45. PubMed ID: 16102970
[TBL] [Abstract][Full Text] [Related]
39. Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum.
Maccarrone M; Rossi S; Bari M; De Chiara V; Fezza F; Musella A; Gasperi V; Prosperetti C; Bernardi G; Finazzi-Agrò A; Cravatt BF; Centonze D
Nat Neurosci; 2008 Feb; 11(2):152-9. PubMed ID: 18204441
[TBL] [Abstract][Full Text] [Related]
40. PGE2 glycerol ester, a COX-2 oxidative metabolite of 2-arachidonoyl glycerol, modulates inhibitory synaptic transmission in mouse hippocampal neurons.
Sang N; Zhang J; Chen C
J Physiol; 2006 May; 572(Pt 3):735-45. PubMed ID: 16484297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
